Terumo Corp (Terumo) is a medical technology company that manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include pharmaceuticals, blood bags, disposable medical devices, nutritional food supplement, cardiovascular systems, vascular grafts, blood glucose monitoring system, medical electronic, peritoneal dialysis, and digital thermometers. The company’s systems find applications in and interventional therapies performed inside blood vessels and cardiac and vascular surgery. Terumo also operates blood centers for collecting blood and processing for addressing the transfusion requirement of patients. The company operates through subsidiaries and associate companies in Japan, China, Europe, North America, South America, Asia Pacific, the Middle East and Africa. Terumo is headquartered in Tokyo, Japan.

Headquarters Japan

Address 2-44-1, Hatagaya, Shibuya-Ku, Tokyo, 151-0072


Telephone 81 3 33748111

No of Employees 28,294

Industry Medical Equipment

Ticker Symbol & Exchange 4543 (TYO)

Revenue (2021) $6.3B 14.6% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX 14.9% (2021 vs 2020)

Market Cap* $21.6B

Net Profit Margin (2021) XXX 0.3% (2021 vs 2020)

* As of and is in US$

Access premium data and analytics for Terumo Corp

430+

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

300+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

60+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

250+

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

50+

Clinical Trials

Determine Terumo Corp go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

13+

Marketed Drugs

Understand Terumo Corp’s commercialized product portfolio to stay one step ahead of the market.

12+

Catalyst Calendar

Proactively evaluate Terumo Corp’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

10+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Terumo Corp’s relevant decision makers and contact details.

3

Pipeline Drugs

Identify which of Terumo Corp’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

3

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Terumo Corp (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Terumo Corp’s likely spend across technology areas enabling you to understand the digital strategy.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Cardiac and Vascular: Nobori
Interventional Systems (TIS): SurGuard
Angiographic Guidewires Surflo
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 New Products/Services In July, Terumo Aortic announced first commercial implant of the Thoraflex hybrid device in the US.
2022 Financing Agreements In July, the company along with others investors invested US$110 million in Orchestra BioMed.
2022 Contracts/Agreements In March, the company and Glooko announced a collaboration to integrate their technologies and create new diabetes data sharing solution.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Terumo Corp Medtronic Plc Becton Dickinson and Co Nipro Corp Merit Medical Systems Inc
Headquarters Japan Ireland United States of America Japan United States of America
City Shibuya-Ku Dublin Franklin Lakes Osaka-Shi South Jordan
State/Province Tokyo - New Jersey Osaka Utah
No. of Employees 28,294 95,000 75,000 36,259 6,446
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Toshiaki Takagi Chairman Executive Board 2022 -
Shinjiro Sato Chief Executive Officer; Director; President Executive Board 2017 -
Kazunori Hirose Chief Manufacturing Officer; Director; Group Managing Executive Officer Executive Board 2022 -
Kyo Nishikawa Chief Human Resources Officer; Managing Executive Officer; Director Executive Board 2021 -
Probir Das Chairman - Terumo Asia Holdings Pte Ltd; Managing Director - Terumo Asia Holdings Pte Ltd; Regional Representative- India and Asia Pacific; Executive Officer Executive Board - -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer